PH27014A - Compounds for the treatment of urinary incontinence - Google Patents

Compounds for the treatment of urinary incontinence Download PDF

Info

Publication number
PH27014A
PH27014A PH39454A PH39454A PH27014A PH 27014 A PH27014 A PH 27014A PH 39454 A PH39454 A PH 39454A PH 39454 A PH39454 A PH 39454A PH 27014 A PH27014 A PH 27014A
Authority
PH
Philippines
Prior art keywords
compounds
lower alkyl
diphenylacetamide
methyl
compound
Prior art date
Application number
PH39454A
Other languages
English (en)
Inventor
Christer Sjogren
Rene Mooberg
Bertil Hansen
Sten Kelve
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of PH27014A publication Critical patent/PH27014A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/40Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Discharge Heating (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Underground Structures, Protecting, Testing And Restoring Foundations (AREA)
  • Dowels (AREA)
  • Table Equipment (AREA)
  • Finger-Pressure Massage (AREA)
PH39454A 1988-11-04 1989-11-03 Compounds for the treatment of urinary incontinence PH27014A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8804003A SE8804003D0 (sv) 1988-11-04 1988-11-04 Compounds for the treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
PH27014A true PH27014A (en) 1993-02-01

Family

ID=20373858

Family Applications (1)

Application Number Title Priority Date Filing Date
PH39454A PH27014A (en) 1988-11-04 1989-11-03 Compounds for the treatment of urinary incontinence

Country Status (22)

Country Link
EP (1) EP0367040B1 (cs)
JP (1) JPH02218652A (cs)
KR (1) KR900007407A (cs)
CN (1) CN1043700A (cs)
AT (1) ATE88460T1 (cs)
AU (1) AU628879B2 (cs)
CA (1) CA2001641A1 (cs)
DD (1) DD289467A5 (cs)
DE (1) DE68906122T2 (cs)
DK (1) DK544689A (cs)
ES (1) ES2054980T3 (cs)
FI (1) FI895229A7 (cs)
HU (1) HU202828B (cs)
IE (1) IE63480B1 (cs)
NO (1) NO894384L (cs)
NZ (1) NZ231243A (cs)
PH (1) PH27014A (cs)
PT (1) PT92189B (cs)
RU (1) RU1833370C (cs)
SE (1) SE8804003D0 (cs)
TW (1) TW197944B (cs)
ZA (1) ZA898385B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192779A (en) * 1989-02-14 1993-03-09 Fujisawa Pharmaceutical Co., Ltd. Substituted-acetamide compound and a process for the preparation thereof
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof
CA2061665C (en) * 1991-02-25 2002-04-16 Mark Mortensen Foreman Treatment of lower urinary tract disorders
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
TW281667B (cs) * 1994-02-03 1996-07-21 Synthelabo
GB0328060D0 (en) * 2003-12-04 2004-01-07 Sod Conseils Rech Applic Botulinum toxin treatment
EP3288527B1 (en) * 2015-04-28 2020-02-19 Unilever PLC, a company registered in England and Wales under company no. 41424 of N-aralkylcarbonyldiamine compounds and personal care compositions comprising the same
US10155733B2 (en) 2015-04-28 2018-12-18 Conopco, Inc. N-aralkylcarbonyl-piperazine and -homopiperazine compounds and personal care compositions comprising the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2009144A (en) * 1935-07-23 Substituted amides of amphatic-
US2831892A (en) * 1956-03-22 1958-04-22 Searle & Co N-(3-isopropylaminopropyl) diphenyl-acetamide and processes
FR2319337A1 (fr) * 1975-07-30 1977-02-25 Fabre Sa Pierre Gem diaryles possedant une activite antiarythmique utile en therapeutique cardiovasculaire
FR2333501A2 (fr) * 1975-12-03 1977-07-01 Science Union & Cie Nouveaux acetamides substitues leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2340724A2 (fr) * 1976-02-13 1977-09-09 Science Union & Cie Nouveaux diarylacetamides substitues, leurs procedes de preparation et les compositions pharmaceutiques en contenant
FR2421891A1 (fr) * 1977-10-17 1979-11-02 Fabre Sa Pierre Obtention industrielle d'amides de la pyrrolidine ethyl amine
FR2421892A1 (fr) * 1977-10-17 1979-11-02 Fabre Sa Pierre Procede de synthese industrielle du n(n' ethyl pyrrolidino-2 methyl) aadiphenylahydroxy acetamide
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof

Also Published As

Publication number Publication date
DE68906122T2 (de) 1997-05-22
AU628879B2 (en) 1992-09-24
HU202828B (en) 1991-04-29
DK544689D0 (da) 1989-11-01
ZA898385B (en) 1990-07-25
RU1833370C (en) 1993-08-07
JPH02218652A (ja) 1990-08-31
KR900007407A (ko) 1990-06-01
EP0367040A1 (en) 1990-05-09
IE63480B1 (en) 1995-05-03
NZ231243A (en) 1994-03-25
DD289467A5 (de) 1991-05-02
CA2001641A1 (en) 1990-05-04
HU895648D0 (en) 1990-01-28
DK544689A (da) 1990-05-05
FI895229A7 (fi) 1990-05-05
PT92189B (pt) 1995-07-18
HUT51597A (en) 1990-05-28
DE68906122D1 (de) 1993-05-27
PT92189A (pt) 1990-05-31
NO894384L (no) 1990-05-07
TW197944B (cs) 1993-01-11
NO894384D0 (no) 1989-11-03
CN1043700A (zh) 1990-07-11
IE893398L (en) 1990-05-04
FI895229A0 (fi) 1989-11-03
AU4439489A (en) 1990-05-10
ES2054980T3 (es) 1994-08-16
ATE88460T1 (de) 1993-05-15
EP0367040B1 (en) 1993-04-21
SE8804003D0 (sv) 1988-11-04

Similar Documents

Publication Publication Date Title
RU2167152C2 (ru) N-замещенные азагетероциклические карбоновые кислоты или их фармацевтически приемлемые соли, способ их получения, фармацевтическая композиция на их основе и способ ингибирования нейрогенного воспаления
US7026320B2 (en) Serotonergic agents
JPH05194513A (ja) 化学中間体
JP2502343B2 (ja) 薬学的に活性な置換ベンズアミド
US6107328A (en) Use of 5HT1B receptor antagonist for the treatment of vascular disease
JP2021517137A (ja) Rock阻害剤としての重水素化合物
PL162318B1 (pl) Sposób wytwarzania nowych pochodnych piperydyny PL PL PL
US5236956A (en) Compounds for the treatment of urinary incontinence
PH27014A (en) Compounds for the treatment of urinary incontinence
JPH0331279A (ja) 新規r(―)3―キヌクリジノール誘導体類
EP0228246A2 (en) Isoquinoline compounds
EP1611126B1 (de) Chromenonindole
EP0254955A2 (de) Substituierte Pyrido-[2,3-b][1,4]benzodiazepin-6-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0312895A2 (de) Kondensierte Diazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0369286A2 (de) Dibenzazepin-Derivate zur Behandlung von akuten und chronischen obstruktiven Atemwegserkrankungen
CA2120215C (en) 2,3-dihydro-4(1h)-quinazolinones active in gastro-intestinal pathologies
US4766119A (en) Antispasmodic alkylated aminothioester derivatives
US4410527A (en) Substituted thienobenzodiazepinones and salts thereof
JP4781362B2 (ja) 4級アンモニウム基を有するキヌクリジン化合物とその調製方法、およびアセチルコリン遮断剤としての用途
PT794184E (pt) Derivados de 6-metoxi-1h-benzotriazolo-5-carboxamida seus processos de producao e composicoes farmaceuticas que os contem
US4652649A (en) Anti-spasmodic agents having a ring in the main chain
US4721722A (en) Anti-spasmodic agents containing quaternary nitrogen
KR20030036834A (ko) 5-페닐벤질아민 화합물, 그의 제법 및 그의 합성 중간체
US7816362B2 (en) Serotonergic agents
US4271161A (en) Indane-acetic acid aminoesters, their preparation and their use in therapy